{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:22:33Z","timestamp":1769599353354,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1049","license":[{"start":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T00:00:00Z","timestamp":1360886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The development of resistance to multiple antimicrobial agents has limited treatment options for gonorrhoea. The potential emergence of cephalosporin resistance in Neisseria gonorrhoeae and cephalosporin allergy in some patients make it necessary to evaluate the effectiveness of other available antimicrobial agents. Gentamicin is widely available in the USA and is used for gonorrhoea treatment in several countries. We conducted a systematic review of the medical literature to assess the effectiveness of gentamicin for treatment of uncomplicated urogenital gonococcal infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Two reviewers assessed relevant articles and independently selected studies that met prespecified selection criteria (including systematic enrolment and assignment to treatment and culture-confirmed diagnosis and outcome). Summary measures for selected studies were pooled using inverse variance-weighted averages with fixed effects. Heterogeneity was assessed using I2, which estimates proportion (0\u2013100%) of variability attributable to heterogeneity between studies. Pooled percentage with negative follow-up culture was compared with Centers for Disease Control and Prevention (CDC) criteria for selection of recommended therapy (lower 95% CI of efficacy \u226595%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-nine potentially relevant studies were identified; three met inclusion criteria. Two studies used 240\u2005mg intramuscular gentamicin and one used 280\u2005mg. Percentages with negative culture after single-dose treatment were 90.7% (n=86), 91.4% (n=220) and 95.0% (n=40). Pooled percentage with negative culture after single-dose treatment was 91.5% (95% CI 88.1% to 94.0%, I2=0%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Gentamicin does not meet current CDC criteria for recommended treatment of gonorrhoea. However, if cephalosporin resistance emerges, gentamicin may be a useful alternative agent. Evaluation of additional regimens, including combination therapy, is warranted.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/postgradmedj-2012-050604rep","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T11:33:01Z","timestamp":1360927981000},"page":"142-147","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis"],"prefix":"10.1093","volume":"89","author":[{"given":"Deborah","family":"Dowell","sequence":"first","affiliation":[{"name":"Division of STD Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Kirkcaldy","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"2023041906100532900_bib1","first-page":"873","article-title":"Cephalosporin susceptibility among Neisseria gonorrhoeae isolates\u2014United States, 2000\u20132010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023041906100532900_bib2","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.48.8.3185-3187.2004","article-title":"Remarkable increase in Central Japan in 2001\u20132002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones","volume":"48","author":"Ito","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041906100532900_bib3","volume-title":"Gonococcal antimicrobial susceptibility surveillance in Europe\u20142010","author":"European Centre for Disease Control and Prevention","year":"2012"},{"key":"2023041906100532900_bib4","doi-asserted-by":"crossref","first-page":"19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Eurosurveillance"},{"key":"2023041906100532900_bib5","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison","year":"2011","journal-title":"Eurosurveillance"},{"key":"2023041906100532900_bib6","doi-asserted-by":"crossref","first-page":"19998","DOI":"10.2807\/ese.16.43.19998-en","article-title":"First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011","volume":"16","author":"Unemo","year":"2011","journal-title":"Eurosurveillance"},{"key":"2023041906100532900_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041906100532900_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007","volume":"37","author":"Brown","year":"2010","journal-title":"Sex Transm Dis"},{"key":"2023041906100532900_bib9"},{"key":"2023041906100532900_bib10","author":"CenterWatch"},{"key":"2023041906100532900_bib11","author":"Current Controlled Trials"},{"key":"2023041906100532900_bib12","author":"World Health Organization International Clinical Trials Registry Platform"},{"key":"2023041906100532900_bib13","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1086\/511422","article-title":"Update on the management of gonorrhea in adults in the United States","volume":"44","author":"Newman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2023041906100532900_bib14","first-page":"384","article-title":"STD\/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation","volume":"70","author":"Lule","year":"1994","journal-title":"Genitourin Med"},{"key":"2023041906100532900_bib15","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1128\/jcm.35.11.2985-2988.1997","article-title":"Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods","volume":"35","author":"Daly","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2023041906100532900_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00007435-198501000-00011","article-title":"Efficacy of gentamicin and kanamycin in the treatment of uncomplicated gonococcal urethritis in Zambia","volume":"12","author":"Hira","year":"1985","journal-title":"Sex Transm Dis"},{"key":"2023041906100532900_bib17","first-page":"62","article-title":"Treatment of gonorrhoea with single injections of gentamicin","volume":"49","author":"Hantschke","year":"1973","journal-title":"Br J Vener Dis"},{"key":"2023041906100532900_bib18","first-page":"394","article-title":"Gentamicin in the treatment of infections due to penicillinase-producing gonococci","volume":"56","author":"Tan","year":"1980","journal-title":"Br J Vener Dis"},{"key":"2023041906100532900_bib19","first-page":"622","article-title":"Einmal-Behandlung der Gonorrhoe bei Frauen mit Gentamycin (in German)","volume":"25","author":"Bartunek","year":"1974","journal-title":"Der Hautarzt"},{"key":"2023041906100532900_bib20","first-page":"208","article-title":"Gentamicin in the treatment of gonorrhea in females","volume":"50","author":"Bowie","year":"1974","journal-title":"Brit J Vener Dis"},{"key":"2023041906100532900_bib21","first-page":"30","article-title":"Einmalige sulmycin (gentamycin)-behandlung der gonorrhoe (in German)","volume":"24","author":"Hantschke","year":"1973","journal-title":"Der Hautarzt"},{"key":"2023041906100532900_bib22","first-page":"407","article-title":"Gonorrhoe-behandlung mit sulmyicn) (in German)","volume":"45","author":"Hantschke","year":"1970","journal-title":"Z Haut-Geschl Kr"},{"key":"2023041906100532900_bib23","first-page":"39","article-title":"(Combined etiological and pathogenetic therapy of urogenital Ureaplasma\u2013Chlamydia-gonococcal infection in men) (in Russian)","volume":"36","author":"Bukharovich","year":"1991","journal-title":"Antibiot Khimioter"},{"key":"2023041906100532900_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00007435-200306000-00009","article-title":"Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial","volume":"30","author":"Price","year":"2003","journal-title":"Sex Transm Dis"},{"key":"2023041906100532900_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.16.3.430-450.2003","article-title":"Versatility of aminoglycosides and prospects for their future","volume":"16","author":"Vakulenko","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"2023041906100532900_bib26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.16.3.430-450.2003","article-title":"Versatility of aminoglycosides and prospects for their future","volume":"16","author":"Vakulenko","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"2023041906100532900_bib27","first-page":"207","article-title":"Aminoglycoside toxicity and relation to dose regimen","volume":"13","author":"Barclay","year":"1994","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"2023041906100532900_bib28","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1093\/infdis\/124.Supplement_1.S130","article-title":"Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States","volume":"124","author":"Jackson","year":"1971","journal-title":"J Infect Dis"},{"key":"2023041906100532900_bib29","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1093\/infdis\/124.Supplement_1.S287","article-title":"Gentamicin in gonococcal urethritis of Filipino males: dosage and response","volume":"124","author":"Felarca","year":"1971","journal-title":"J Infect Dis"},{"key":"2023041906100532900_bib30","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/20.Supplement_1.S47","article-title":"Drugs of choice for the treatment of uncomplicated gonococcal infections","volume":"20","author":"Moran","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2023041906100532900_bib31","first-page":"33","article-title":"Treatment of gonorrhea in pregnancy","volume":"81","author":"Cavenee","year":"1993","journal-title":"Obstet Gynecol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1049\/142\/50017269\/postgradmedj-89-142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1049\/142\/50017269\/postgradmedj-89-142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T06:14:36Z","timestamp":1681884876000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/89\/1049\/142\/6987475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":31,"journal-issue":{"issue":"1049","published-online":{"date-parts":[[2013,2,15]]},"published-print":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2012-050604rep","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,3]]},"published":{"date-parts":[[2013,2,15]]}}}